Development of resistance to 5-fluorouracil affects membrane viscosity and lipid composition of cancer cells.

5-fluorouracil cancer cells chemoresistance fluorescence lifetime imaging microscopy FLIM molecular rotor plasma membrane microviscosity time-of-flight secondary ion mass spectrometry ToF-SIMS

Journal

Methods and applications in fluorescence
ISSN: 2050-6120
Titre abrégé: Methods Appl Fluoresc
Pays: England
ID NLM: 101608648

Informations de publication

Date de publication:
25 Aug 2022
Historique:
received: 24 02 2022
accepted: 15 08 2022
pubmed: 16 8 2022
medline: 26 8 2022
entrez: 15 8 2022
Statut: epublish

Résumé

The investigations reported here were designed to determine whether the bulk plasma membrane is involved in mechanisms of acquired resistance of colorectal cancer cells to 5-fluorouracil (5-FU). Fluorescence lifetime imaging microscopy (FLIM) of live cultured cells stained with viscosity-sensitive probe BODIPY 2 was exploited to non-invasively assess viscosity in the course of treatment and adaptation to the drug. In parallel, lipid composition of membranes was examined with the time-of-flight secondary ion mass spectrometry (ToF-SIMS). Our results showed that a single treatment with 5-FU induced only temporal changes of viscosity in 5-FU sensitive cells immediately after adding the drug. Acquisition of chemoresistance was accompanied by persistent increase of viscosity, which was preserved upon treatment without any changes. Lipidomic analysis revealed that the resistant cells had a lower level of monounsaturated fatty acids and increased sphingomyelin or decreased phosphatidylcholine in their membranes, which partly explain increase of the viscosity. Thus, we propose that a high membrane viscosity mediates the acquisition of resistance to 5-FU.

Identifiants

pubmed: 35970177
doi: 10.1088/2050-6120/ac89cd
doi:

Substances chimiques

Phosphatidylcholines 0
Fluorouracil U3P01618RT

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2022 IOP Publishing Ltd.

Auteurs

Liubov Shimolina (L)

Institute of Experimental Oncology and Biomedical Technologies, Privolzhsky Research Medical University, Minin and Pozharsky Square, 10/1, 603005 Nizhny Novgorod, Russia.

Alexander Gulin (A)

N.N. Semenov Federal Research Center for Chemical Physics, Russian Academy of Sciences, Kosygin st. 4, 119991 Moscow, Russia.

Aleksandra Khlynova (A)

Institute of Experimental Oncology and Biomedical Technologies, Privolzhsky Research Medical University, Minin and Pozharsky Square, 10/1, 603005 Nizhny Novgorod, Russia.

Nadezhda Ignatova (N)

Institute of Experimental Oncology and Biomedical Technologies, Privolzhsky Research Medical University, Minin and Pozharsky Square, 10/1, 603005 Nizhny Novgorod, Russia.

Irina Druzhkova (I)

Institute of Experimental Oncology and Biomedical Technologies, Privolzhsky Research Medical University, Minin and Pozharsky Square, 10/1, 603005 Nizhny Novgorod, Russia.

Margarita Gubina (M)

N.N. Semenov Federal Research Center for Chemical Physics, Russian Academy of Sciences, Kosygin st. 4, 119991 Moscow, Russia.

Elena Zagaynova (E)

Institute of Biology and Biomedicine, Nizhny Novgorod State University, Gagarin Avenue 23, 603950 Nizhny Novgorod, Russia.

Marina K Kuimova (MK)

Department of Chemistry, Faculty of Natural Sciences, Imperial College London, South Kensington, London SW7 2AZ, United Kingdom.

Marina Shirmanova (M)

Institute of Experimental Oncology and Biomedical Technologies, Privolzhsky Research Medical University, Minin and Pozharsky Square, 10/1, 603005 Nizhny Novgorod, Russia.

Articles similaires

Humans Male Female Health Knowledge, Attitudes, Practice Middle Aged
Humans Neoplasms Male Female Middle Aged
Humans Middle Aged Female Male Surveys and Questionnaires
Humans Receptors, Antigen, T-Cell Proto-Oncogene Proteins p21(ras) Pancreatic Neoplasms T-Lymphocytes

Classifications MeSH